Combined synopsis and solicitation, total small business set-aside
BioProfile FLEX2 Parts and Component
75F40125Q00195
Food and Drug Administration, FDA Office of Operations. Analytical Laboratory Instrument Manufacturing.
Response deadline
June 11, 2025 at 12:00 PM EDT
Closed 464 days ago. Posted May 28, 2025, first published April 29, 2025. Scheduled to archive June 26, 2025.
Description
As published on SAM.gov.
THIS IS NOT A REQUEST FOR PROPOSAL This is a combined synopsis/solicitation for Commercial Items prepared in accordance with the format in FAR Subpart 12.6, Simplified Procedures for Evaluation and Solicitation for Commercial Items, and 13.5, Simplified Procedures for Certain Commercial Items, as supplemented with additional information included in this notice. FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services, provisions apply to this acquisition.
The applicability of FAR 52.212-2, Evaluation-Commercial Products and Commercial Services provisions, and the specific evaluation criteria to be included in paragraph (a) of that provision, do not apply to this acquisition. The evaluation procedures to be used under this acquisition are prescribed under Basis of Award section in the SOW.
Offerors shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services, with their offers.FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services provisions, apply to this acquisition. FAR 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders-Commercial Products and Commercial Services provisions, apply to this acquisition.
This announcement constitutes the only solicitation that will be issued; proposals are being requested and a written solicitation will not be issued. This requirement is being solicited as a SMALL BUSINESS SET-ASIDE and the Government contemplates a Firm-Fixed Price Purchase Order will result from this RFP. The Solicitation Number is 75F40125Q00195.
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2020-05 dated March 2020. The associated North American Industrial Classification System (NAICS) code for this acquisition is 334516, Analytical Instruments Includes analytical equipment for laboratory use, such as testing equipment, etc. The Government reserves the right to award a purchase order/contract without additional communication. NO FURTHER SOLICITATION WILL BE ISSUED.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
April 29, 2025
Combined synopsis and solicitation
Due May 14, 2025 at 12:00 PM EDT. SAM.gov, notice 15c41a47d6134d858c1392922c65317b
April 29, 2025
Combined synopsis and solicitation
Due May 14, 2025 at 12:00 PM EDT. SAM.gov, notice c17f8d5e4e3e490585767210fa55b289
May 28, 2025
Combined synopsis and solicitation
Due June 11, 2025 at 12:00 PM EDT. SAM.gov, notice 89d6d1b7c3fb412dafba2542b817f8bf
May 28, 2025
Combined synopsis and solicitation
Due June 11, 2025 at 12:00 PM EDT. SAM.gov, notice 9c6b714bde294b959c7acc84fd2a9662
Points of contact
- Natapol SirikhanNatapol.Sirikhan@fda.hhs.gov2404028031